🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Several experts said the demand for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Removal

Based on the social media company, the platform has removed violative content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Information and Costs

Inside these groups, messages show dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.